Search

everythinglearnresearchcommunity

for

Search:↓

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Hydroxychloroquine may help delay skin damage in lupus patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Type I interferons play a key role in the development of various skin diseases.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.